Cargando…
The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases
BACKGROUND: Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminths (STH) and trachoma represent the five most prevalent neglected tropical diseases (NTDs). They can be controlled or eliminated by means of safe and cost-effective interventions delivered through program...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313231/ https://www.ncbi.nlm.nih.gov/pubmed/28103243 http://dx.doi.org/10.1371/journal.pntd.0005289 |
_version_ | 1782508325407031296 |
---|---|
author | Redekop, William K. Lenk, Edeltraud J. Luyendijk, Marianne Fitzpatrick, Christopher Niessen, Louis Stolk, Wilma A. Tediosi, Fabrizio Rijnsburger, Adriana J. Bakker, Roel Hontelez, Jan A. C. Richardus, Jan H. Jacobson, Julie de Vlas, Sake J. Severens, Johan L. |
author_facet | Redekop, William K. Lenk, Edeltraud J. Luyendijk, Marianne Fitzpatrick, Christopher Niessen, Louis Stolk, Wilma A. Tediosi, Fabrizio Rijnsburger, Adriana J. Bakker, Roel Hontelez, Jan A. C. Richardus, Jan H. Jacobson, Julie de Vlas, Sake J. Severens, Johan L. |
author_sort | Redekop, William K. |
collection | PubMed |
description | BACKGROUND: Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminths (STH) and trachoma represent the five most prevalent neglected tropical diseases (NTDs). They can be controlled or eliminated by means of safe and cost-effective interventions delivered through programs of Mass Drug Administration (MDA)—also named Preventive Chemotherapy (PCT). The WHO defined targets for NTD control/elimination by 2020, reinforced by the 2012 London Declaration, which, if achieved, would result in dramatic health gains. We estimated the potential economic benefit of achieving these targets, focusing specifically on productivity and out-of-pocket payments. METHODS: Productivity loss was calculated by combining disease frequency with productivity loss from the disease, from the perspective of affected individuals. Productivity gain was calculated by deducting the total loss expected in the target achievement scenario from the loss in a counterfactual scenario where it was assumed the pre-intervention situation in 1990 regarding NTDs would continue unabated until 2030. Economic benefits from out-of-pocket payments (OPPs) were calculated similarly. Benefits are reported in 2005 US$ (purchasing power parity-adjusted and discounted at 3% per annum from 2010). Sensitivity analyses were used to assess the influence of changes in input parameters. RESULTS: The economic benefit from productivity gain was estimated to be I$251 billion in 2011–2020 and I$313 billion in 2021–2030, considerably greater than the total OPPs averted of I$0.72 billion and I$0.96 billion in the same periods. The net benefit is expected to be US$ 27.4 and US$ 42.8 for every dollar invested during the same periods. Impact varies between NTDs and regions, since it is determined by disease prevalence and extent of disease-related productivity loss. CONCLUSION: Achieving the PCT-NTD targets for 2020 will yield significant economic benefits to affected individuals. Despite large uncertainty, these benefits far exceed the investment required by governments and their development partners within all reasonable scenarios. Given the concentration of the NTDs among the poorest households, these investments represent good value for money in efforts to share the world’s prosperity and reduce inequity. |
format | Online Article Text |
id | pubmed-5313231 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-53132312017-03-03 The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases Redekop, William K. Lenk, Edeltraud J. Luyendijk, Marianne Fitzpatrick, Christopher Niessen, Louis Stolk, Wilma A. Tediosi, Fabrizio Rijnsburger, Adriana J. Bakker, Roel Hontelez, Jan A. C. Richardus, Jan H. Jacobson, Julie de Vlas, Sake J. Severens, Johan L. PLoS Negl Trop Dis Research Article BACKGROUND: Lymphatic filariasis (LF), onchocerciasis, schistosomiasis, soil-transmitted helminths (STH) and trachoma represent the five most prevalent neglected tropical diseases (NTDs). They can be controlled or eliminated by means of safe and cost-effective interventions delivered through programs of Mass Drug Administration (MDA)—also named Preventive Chemotherapy (PCT). The WHO defined targets for NTD control/elimination by 2020, reinforced by the 2012 London Declaration, which, if achieved, would result in dramatic health gains. We estimated the potential economic benefit of achieving these targets, focusing specifically on productivity and out-of-pocket payments. METHODS: Productivity loss was calculated by combining disease frequency with productivity loss from the disease, from the perspective of affected individuals. Productivity gain was calculated by deducting the total loss expected in the target achievement scenario from the loss in a counterfactual scenario where it was assumed the pre-intervention situation in 1990 regarding NTDs would continue unabated until 2030. Economic benefits from out-of-pocket payments (OPPs) were calculated similarly. Benefits are reported in 2005 US$ (purchasing power parity-adjusted and discounted at 3% per annum from 2010). Sensitivity analyses were used to assess the influence of changes in input parameters. RESULTS: The economic benefit from productivity gain was estimated to be I$251 billion in 2011–2020 and I$313 billion in 2021–2030, considerably greater than the total OPPs averted of I$0.72 billion and I$0.96 billion in the same periods. The net benefit is expected to be US$ 27.4 and US$ 42.8 for every dollar invested during the same periods. Impact varies between NTDs and regions, since it is determined by disease prevalence and extent of disease-related productivity loss. CONCLUSION: Achieving the PCT-NTD targets for 2020 will yield significant economic benefits to affected individuals. Despite large uncertainty, these benefits far exceed the investment required by governments and their development partners within all reasonable scenarios. Given the concentration of the NTDs among the poorest households, these investments represent good value for money in efforts to share the world’s prosperity and reduce inequity. Public Library of Science 2017-01-19 /pmc/articles/PMC5313231/ /pubmed/28103243 http://dx.doi.org/10.1371/journal.pntd.0005289 Text en © 2017 Redekop et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Redekop, William K. Lenk, Edeltraud J. Luyendijk, Marianne Fitzpatrick, Christopher Niessen, Louis Stolk, Wilma A. Tediosi, Fabrizio Rijnsburger, Adriana J. Bakker, Roel Hontelez, Jan A. C. Richardus, Jan H. Jacobson, Julie de Vlas, Sake J. Severens, Johan L. The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
title | The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
title_full | The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
title_fullStr | The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
title_full_unstemmed | The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
title_short | The Socioeconomic Benefit to Individuals of Achieving the 2020 Targets for Five Preventive Chemotherapy Neglected Tropical Diseases |
title_sort | socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5313231/ https://www.ncbi.nlm.nih.gov/pubmed/28103243 http://dx.doi.org/10.1371/journal.pntd.0005289 |
work_keys_str_mv | AT redekopwilliamk thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT lenkedeltraudj thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT luyendijkmarianne thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT fitzpatrickchristopher thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT niessenlouis thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT stolkwilmaa thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT tediosifabrizio thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT rijnsburgeradrianaj thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT bakkerroel thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT hontelezjanac thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT richardusjanh thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT jacobsonjulie thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT devlassakej thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT severensjohanl thesocioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT redekopwilliamk socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT lenkedeltraudj socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT luyendijkmarianne socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT fitzpatrickchristopher socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT niessenlouis socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT stolkwilmaa socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT tediosifabrizio socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT rijnsburgeradrianaj socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT bakkerroel socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT hontelezjanac socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT richardusjanh socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT jacobsonjulie socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT devlassakej socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases AT severensjohanl socioeconomicbenefittoindividualsofachievingthe2020targetsforfivepreventivechemotherapyneglectedtropicaldiseases |